Vitae Pharmaceuticals, NASDAQ:VTAE, VTAE

Baxter International Inc (BAX) will present at the 38th Annual Raymond James Institutional Shareholder Conference on Tuesday, March 7, 2017 in Orlando. Jay Saccaro, Baxter’s chief financial officer, is planned to present at 7:30 a.m. Eastern Standard Time.

The live webcast of Baxter’s presentation can be accessed at and will be available for replay through May 7, 2017.

Baxter provides a broad portfolio of essential renal and hospital products, counting home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that facilitate patient care.

Genocea Biosciences Inc (GNCA) announced that it will host a conference call and live audio webcast on Thursday, February 16, 2017 at 9:00 a.m. ET to discuss financial results for the fourth quarter and year end 2016. Genocea management will provide an update on the Company’s recent progress and upcoming milestones.

Interested participants and investors may access the conference call by dialing (844) 826-0619 (domestic) or (315) 625-6883 (international) and refer to conference ID number 58691835. To join the live webcast please visit the investor relations section of the Genocea website at

A webcast replay will be available on the Genocea website beginning approximately two hours after the event, and will be archived for 30 days.



Please enter your comment!
Please enter your name here